BATS BZX Real-Time Price
As of 2:59pm ET
| -0.34 / -2.83%|
The 6 analysts offering 12-month price forecasts for Trinity Biotech PLC have a median target of 23.00, with a high estimate of 28.00 and a low estimate of 20.00. The median estimate represents a +97.09% increase from the last price of 11.67.
The current consensus among 7 polled investment analysts is to Buy stock in Trinity Biotech PLC. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.